June 7, 2019 / 11:18 PM / 4 months ago

Takeda loses 'spurious' bid to DQ Baker Botts in antitrust case

Takeda Pharmaceutical Company on Thursday lost a bid to disqualify Baker Botts from representing generic drug company Zydus Pharmaceuticals Inc in a lawsuit accusing Takeda of an antitrust violation.

Affirming a magistrate judge, U.S. District Judge Freda Wolfson in Trenton, New Jersey rejected Takeda’s argument that it had an implied attorney-client relationship with Baker Botts because of the firm’s previous representation of Takeda’s co-plaintiff in related patent litigation.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2IspGBF

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below